German Demand For Medical Marijuana Imports Continue To Grow

09/02/20 01:16PM EDT

Below is a complimentary excerpt from an institutional research note written by our Cannabis analysts Howard Penney and Daniel BiolsiIf you are an institutional investor interested in accessing our research email

German Demand For Medical Marijuana Imports Continue To Grow - 9 2 2020 1 11 54 PM

In Germany, demand for medical marijuana imports are set to grow by 37%

A recent press release from Germany’s federal government estimates that medical marijuana imports are expected to reach 28,455 kgs in 2020, a 37% increase YoY.

Dr. Armin Prasch, Head of the BvCW (German cannabis industry association), commented, “With the cannabis industry, we see an ongoing, growing, and stable market in the medical cannabis space. This confirms our prognoses. We attribute the expected increase of approximately 37% compared to 2019 to the increasing knowledge of doctors in therapeutic use and increased demand on the part of patients, which could be explained by the changing public perception of the possible uses of cannabis as a therapeutic agent” (Translation).

While medical marijuana has been available by prescription since March 2017 in Germany, the country’s medical marijuana market is still dependent on cannabis grown abroad.

The German government has limited domestic cannabis production to 2,600 kgs per year, not nearly enough to meet demand in the country. Germany’s reliance on imports makes it an exceptionally attractive market to Canadian LPs (APHA, TLRY, CRON, CGC, and ACB) seeking to gain a foothold in the EU and offload excess inventory.

The German Federal Institute for Drugs and Medical Devices (BfArM) has authorized companies from Canada, the Netherlands, Austria, Switzerland, Portugal, Spain, Israel, Colombia, and Uruguay to export medical marijuana to Germany.

German Demand For Medical Marijuana Imports Continue To Grow - jh4

© 2020 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.